HbA1c ReductionUsual care

Clinical evidence dossier

Usual care

HbA1c

Evidence signal

Authoritative evidence signal

strong

This is an authoritative evidence signal supplied by Clinical Reference. It is not a formal clinical grade, treatment recommendation, or pooled effect estimate.

Evidence snapshot

Authoritative support records
10
Supporting studies available for review
10
Randomized trials
10
Reported effects
18

Clinical conclusion

Usual care has a small positive evidence signal for HbA1c, but the clinical interpretation is limited.

The conclusion and evidence-signal classification are distinct authoritative fields and are reproduced as published.

Observed effects

Observed study estimates; not a pooled treatment effect.

Change from baseline

Absolute change

-1.5 to 0 %

3 eligible estimates8–12 weeksObserved median: -0.3 %

Between-group effect

Absolute change

-0.5 to -0.5 %

1 eligible estimates12–12 weeksObserved median: -0.5 %

Change from baseline

Mean difference

-1.75 to 0 %

5 eligible estimates12–24 weeksObserved median: -1.3 %

Between-group effect

Mean difference

-1.07 to 0.2 %

5 eligible estimates12–24 weeksObserved median: -0.46 %

Between-group effect

Mean difference

-0.17 to 0 percentage

2 eligible estimates12–12 weeksObserved median: -0.085 percentage

Evidence composition

Non-randomized studies
0
Other designs
0
Unresolved designs
0
Magnitude-eligible effects
16

Consistency

Authoritative consistency classification

consistent

Positive
1
No effect
8
Mixed
1
Negative
0

Population and applicability

Structured population data were available for 10 of 10 supporting studies. Diabetes type was heterogeneous: 8 studies with type 2 diabetes, 2 studies with type 1 diabetes. Age groups were heterogeneous: 8 studies with adult participants, 1 studies with youth participants.

This population information refers to the materialized supporting studies available for review. Omitted support records remain part of the authoritative support accounting and are available through the audit experience.

View reported population descriptions

These descriptions are reported across the supporting studies; they are not a single synthesized population.

  • Adults with elevated HbA1c levels.
  • Individuals seeking lifestyle interventions for weight management.
  • Patients with type 2 diabetes.
  • Adults diagnosed with type 2 diabetes mellitus.
  • Patients experiencing sleep disturbances related to diabetes.
  • Adults and children with type 1 diabetes.
  • Individuals living in rural areas with limited access to diabetes care.
  • Adults with type 2 diabetes.
  • Patients seeking digital health interventions for diabetes management.
  • Adults diagnosed with type 2 diabetes.
  • Individuals seeking dietary interventions for diabetes management.
  • Adults diagnosed with Type 2 Diabetes Mellitus.

Limitations

  • Evidence uses heterogeneous comparison contexts: active_comparator, other, usual_care.
  • 1 supporting study has high, serious, critical, unclear, or unavailable risk-of-bias information.
  • 3 studies contain conflicting p-value and significance fields; those significance claims are suppressed.

Supporting evidence

Inspect the authoritative studies and omitted support records for this dossier.

View supporting evidence